Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

Study (n=78,674 across 255 health-care facilities in England, Scotland, and Wales, of which 4205 NSAID users matched to 4205 non users) found that NSAID use was not associated with higher mortality (OR 0.95, 95% CI 0.84–1.07; p=0.35) or increased severity of COVID-19.

The Lancet Rheumatology